Skip to main content
. 2008 Sep 26;26(41):5269–5275. doi: 10.1016/j.vaccine.2008.07.040

Fig. 2.

Fig. 2

Immune responses to the recall antigen SK/SD are increased at both weeks 1 and 12 in BCG primed subjects vaccinated with MVA85A (n = 9) (Wilcoxon). Box and whisker plots showing median, 25th and 75th percentiles.